Thursday, November 15, 2012
Publication and contact
Microfluidic device to
model IL-2-induced pulmonary
In vitro studies suggest a microfluidic device could be used
to model pulmonary edema and identify molecules to prevent the disease. The
device consists of human alveolar epithelial cells and pulmonary
microvascular cells separated by a porous membrane that is subjected to
mechanical strain to mimic breathing. In the chip, exposure to IL-2, a cancer
therapy that causes pulmonary edema as a side effect, increased vascular
permeability and fluid leak into the alveolar air space compared with no
treatment. These effects were inhibited by angiopoietin 1 (ANG1; ANGPT1) or a transient receptor potential vanilloid 4 (TRPV4; VRL2) inhibitor. Next steps
include additional studies to confirm that data from the chips can replace
animal model data.
Published online Nov. 15, 2012
Patents filed; available
Huh, D. et al. Sci.
Transl. Med.; published online Nov. 11, 2012;
Contact: Donald E. Ingber, Harvard University,
Contact: Geraldine A. Hamilton, same affiliation as above
All contents Copyright © 1993-2017 BioCentury Publications, Inc. ALL RIGHTS RESERVED. All use of this Web Site and its contents is governed by the BioCentury User Agreement
. The contents of this Web Site are protected under U.S. and foreign copyright and intellectual property laws, and no part of this Web Site or its contents may be photocopied, reproduced or retransmitted in any form without the written consent of BioCentury, which may be requested from Reprints/Permissions
. BioCentury®; The Bernstein Report on BioBusiness™; The BioCentury 100™; The Clear Route to ROI™; Because Real Intelligence is Hard to Find™; BCIQ™; and BioPharma's Knowledge Center™; are trademarks of BioCentury Publications, Inc., P.O. Box 1246, San Carlos, CA 94070. SciBX® and SciBX: Science-Business eXchange® are trademarks of Nature America, Inc. that are jointly used by BioCentury Publications, Inc. and Nature America, Inc.
Thanks for purchasing this article.
Please bookmark this url for future reference.
We have also sent you a confirming e-mail with a receipt and this same url for your
close [ X ]